Skip to content

A Clinical Study on How Intimate Hygiene Products Affect the Vaginal Ecosystem and Infection Risk in Indian Women

Effect of Feminine Intimate Hygiene Wash Products on Vulvovaginitis Risk and Vaginal Microbiome Profile in Indian Women of Reproductive Age-Group: A Pragmatic Randomized Controlled Trial - NIL

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/107879
Enrollment
325
Registered
2026-04-08
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: Z298- Encounter for other specified prophylactic measures

Interventions

Intervention1: Discourage and stop use of feminine intimate hygienic wash products: 1) Intervention arm in which the use of feminine intimate vaginal hygiene wash products for vaginal irrigation will

Sponsors

Department of Health Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Healthy females of childbearing age group (15-49 years) presenting in Obstetrics and Gynecology OPD of KIMS Hospital, Bhubaneswar using feminine intimate hygiene products for 1 month or more without signs and symptoms of vulvovaginitis at presentation.

Exclusion criteria

Exclusion criteria: 1. Pregnant women will be excluded 2. Women with Diabetes. 3. Male partner having concurrent genital infection. 4. Long term antibiotic and steroid users. 5. Taking immunosuppressant or any other immunosuppressive diseases. 6. Malignancy. 7. Current signs and symptoms of vulvovaginitis or vaginosis

Design outcomes

Primary

MeasureTime frame
Primary outcome measure- The primary outcome which is being followed is the occurrence of vulvovaginitis or the recurrence of vulvovaginitis in the intervention vs comparator groups. This will be done at 6 and 12 months from enrollment.Timepoint: At 6 months and 12 months from enrolment. Primary outcome measure- The primary outcome which is being followed is the occurrence of vulvovaginitis or the recurrence of vulvovaginitis in the intervention vs comparator groups.

Secondary

MeasureTime frame
Vaginal microbiome profile in the intervention vs comparator groups at baseline, 6 months & 12 months from enrolment.Timepoint: Vaginal microbiome profile in the intervention vs comparator groups at baseline,6 months & 12 months from enrolment

Countries

India

Contacts

Public ContactIra Praharaj

Indian Council of Medical Research

ira.praharaj@gmail.com9751442591

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026